The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
Abstract
BACKGROUND: The efficacy of tenofovir disoproxil fumarate (TDF) as part of combination antiretroviral treatment (ART) has been demonstrated in several randomized, controlled trials. However, an increasing number of case reports suggest that TDF use may be associated with significant nephrotoxicity. Our objective was to determine the renal safety of TDF-containing ART regimens for HIV-infected individuals. METHODS: MEDLINE, EMBASE, Global Health, Scopus, Biosis Previews, Cochrane Library, Web of Science, and existing systematic reviews were searched. Prospective studies comparing TDF-containing with non-TDF containing ART regimens were selected for inclusion. We extracted data on study characteristics, participant characteristics, therapeutic interventions, renal function, bone density, and fracture rates. RESULTS: A total of 17 studies (including 9 randomized, controlled trials) met the selection criteria. Median sample size was 517 participants. Constituent ART regimens were diverse. There was a significantly greater loss of kidney function among the TDF recipients, compared with control subjects (mean difference in calculated creatinine clearance, 3.92 mL/min; 95% confidence interval [CI], 2.13-5.70 mL/min), as well as a greater risk of acute renal failure (risk difference, 0.7%; 95% CI, 0.2-1.2). There was no evidence that TDF use led to increased risk of severe proteinuria, hypophosphatemia, or fractures. CONCLUSIONS: Although TDF use was associated with a statistically significant loss of renal function, the clinical magnitude of this effect was modest. Our findings do not support the need to restrict TDF use in jurisdictions where regular monitoring of renal function and serum phosphate levels is impractical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 581
Clumeck, N., Pozniak, A., Raffi, F., & the EACS Executive Committee (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00533.x · Cited by 383
Karras, A., Lafaurie, M., Furco, A., Bourgarit, A., Droz, D., Sereni, D., Legendre, C., Martinez, F., & Molina, J. (2003) · Clinical Infectious Diseases · doi:10.1086/368314 · Cited by 361
Nelson, M. R., Katlama, C., Montaner, J. S., Cooper, D. A., Gazzard, B., Clotet, B., Lazzarin, A., Schewe, K., Lange, J., Wyatt, C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3280b07b33 · Cited by 352
Fanconi syndrome and renal failure induced by tenofovir: A first case report
Verhelst, D., Monge, M., Meynard, J.-L., Fouqueray, B., Mougenot, B., Girard, P.-M., Ronco, P., & Rossert, J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36924 · Cited by 349
Barditch-Crovo, P., Deeks, S. G., Collier, A., Safrin, S., Coakley, D. F., Miller, M., Kearney, B. P., Coleman, R. L., Lamy, P. D., Kahn, J. O., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2733-2739.2001 · Cited by 330
The Quality of Drug Studies Published in Symposium Proceedings
Cho, M. K., & Bero, L. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-5-199603010-00004 · Cited by 328
Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions
Zimmermann, A. E., Pizzoferrato, T., Bedford, J., Morris, A., Hoffman, R., & Braden, G. (2006) · Clinical Infectious Diseases · doi:10.1086/499048 · Cited by 314
Gallant, J. E., Parish, M. A., Keruly, J. C., & Moore, R. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428840 · Cited by 302
Goicoechea, M., Liu, S., Best, B., Sun, S., Jain, S., Kemper, C., Witt, M., Diamond, C., Haubrich, R., Louie, S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524061 · Cited by 299
Wiebe, N., Vandermeer, B., Platt, R. W., Klassen, T. P., Moher, D., & Barrowman, N. J. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.08.017 · Cited by 296
Self-citationMoyle, G. J., Sabin, C. A., Cartledge, J., Johnson, M., Wilkins, E., Churchill, D., Hay, P., Fakoya, A., Murphy, M., Scullard, G., et al. (2006) · AIDS · doi:10.1097/01.aids.0000247574.33998.03 · Cited by 273
Schooley, R. T., Ruane, P., Myers, R. A., Beall, G., Lampiris, H., Berger, D., Chen, S.-S., Miller, M. D., Isaacson, E., & Cheng, A. K. (2002) · AIDS · doi:10.1097/00002030-200206140-00008 · Cited by 270
Renal Tubular Dysfunction Associated With Tenofovir Therapy: Report of 7 Cases
Peyri??re, H., Reynes, J., Rouanet, I., Daniel, N., de Boever, C. M., Mauboussin, J.-M., Leray, H., Moachon, L., Vincent, D., & Salmon-C??ron, D. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00007 · Cited by 262
Cihlar, T., Ho, E. S., Lin, D. C., & Mulato, A. S. (2001) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1081/ncn-100002341 · Cited by 241
Rodríguez‐Nóvoa, S., Labarga, P., Soriano, V., Egan, D., Albalater, M., Morello, J., Cuenca, L., González‐Pardo, G., Khoo, S., Back, D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598507 · Cited by 241
Arribas, J. R., Pozniak, A. L., Gallant, J. E., DeJesus, E., Gazzard, B., Campo, R. E., Chen, S.-S., McColl, D., Holmes, C. B., Enejosa, J., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815acab8 · Cited by 235
Smith, K. Y., Patel, P., Fine, D., Bellos, N., Sloan, L., Lackey, P., Kumar, P. N., Sutherland-Phillips, D. H., Vavro, C., Yau, L., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832cbcc2 · Cited by 217
Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection: A Randomized Trial
Squires, K., Pozniak, A. L., Pierone, G., Steinhart, C. R., Berger, D., Bellos, N. C., Becker, S. L., Wulfsohn, M., Miller, M. D., Toole, J. J., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00006 · Cited by 198
Tenofovir renal toxicity targets mitochondria of renal proximal tubules
Kohler, J. J., Hosseini, S. H., Hoying-Brandt, A., Green, E., Johnson, D. M., Russ, R., Tran, D., Raper, C. M., Santoianni, R., & Lewis, W. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.14 · Cited by 195
Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting System
Gupta, S. K. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.0052 · Cited by 181
Renal safety of tenofovir in HIV treatment-experienced patients
Izzedine, H., Isnard-Bagnis, C., Hulot, J. S., Vittecoq, D., Cheng, A., Jais, C. K., Launay-Vacher, V., & Deray, G. (2004) · AIDS · doi:10.1097/00002030-200404300-00019 · Cited by 173
Rompay, K. K. A. V., Brignolo, L. L., Meyer, D. J., Jerome, C. P., Tarara, R. P., Spinner, A., Hamilton, M., Hirst, L. L., Bennett, D. R., Canfield, D. R., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1469-1487.2004 · Cited by 140
DeJesus, E., Young, B., Morales-Ramirez, J. O., Sloan, L. M., Ward, D. J., Flaherty, J. F., Ebrahimi, R., Maa, J., Reilly, K., Ecker, J., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a572cf · Cited by 135
Fux, C. A., Simcock, M., Wolbers, M., Bucher, H. C., Hirschel, B. J., Opravil, M., Vernazza, P., Cavassini, M. L., Bernasconi, E., Elzi, L., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200812 · Cited by 134
Spectrum of chronic kidney disease in HIV‐infected patients
Campbell, L., Ibrahim, F., Fisher, M., Holt, S. G., Hendry, B., & Post, F. A. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00691.x · Cited by 132
Rollot, F., Nazal, E.-M., Chauvelot‐Moachon, L., Kelaïdi, C., Daniel, N., Saba, M., Abad, S., & Blanche, P. (2003) · Clinical Infectious Diseases · doi:10.1086/379829 · Cited by 131
Renal lesions in HIV-1-positive patient treated with tenofovir
Créput, C., Gonzalez-Canali, G., Hill, G. S., Piketty, C., Kazatchkine, M. D., & Nochy, D. (2003) · AIDS · doi:10.1097/00002030-200304110-00026 · Cited by 116
Calmy, A., Klement-Frutos, E., Teck, R., Berman, D., Pécoul, B., & Ferradini, L. (2004) · PubMed · Cited by 115
Schaaf, B., Aries, S. P., Kramme, E., Steinhoff, J., & Dalhoff, K. (2003) · Clinical Infectious Diseases · doi:10.1086/376643 · Cited by 98
Winston, A., Amin, J., Mallon, P. W. G., Marriott, D., Carr, A. D., Cooper, D., & Emery, S. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00349.x · Cited by 94
Martínez, E., Arranz, J. A., Podzamczer, D., Loncà, M., Sanz, J., Barragán, P., Ribera, E., Knobel, H., Roca, V., Gutiérrez, F., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181aa12d5 · Cited by 84
Overton, E. T., Nurutdinova, D., Freeman, J., Seyfried, W., & Mondy, K. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00693.x · Cited by 81
Progressive Renal Tubular Dysfunction Associated with Long-Term Use of Tenofovir DF
Kinai, E., & Hanabusa, H. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0202 · Cited by 81
HIV-1 Infection and the Kidney: An Evolving Challenge in HIV Medicine
de Silva, T. I., Post, F. A., Griffin, M. D., & Dockrell, D. H. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1103 · Cited by 63
Young, B., Buchacz, K. A., Baker, R. K., Moorman, A. C., Wood, K. C., Chmiel, J. S., Brooks, J. T., & Hiv Outpatient Study Investigators (2007) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109707300676 · Cited by 56
Crane, H. M., Kestenbaum, B. R., Harrington, R. D., & Kitahata, M. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281fc9320 · Cited by 45
Irizarry-Alvarado, J. M., Dwyer, J. P., Brumble, L. M., Álvarez, S., & Mendez, J. (2009) · PubMed · Cited by 39
Tenofovir-Associated Nephrotoxicity in Two HIV-Infected Adolescent Males
Wood, S. M., Shah, S. S., Steenhoff, A. P., Meyers, K. E. C., Kaplan, B. S., & Rutstein, R. M. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0106 · Cited by 38
Acute tubular necrosis in a patient receiving tenofovir
Lee, J. C., & Marosok, R. D. (2003) · AIDS · doi:10.1097/00002030-200311210-00021 · Cited by 35
Guaraldi, G., Roverato, A., Giovanardi, C., Ravera, F., Squillace, N., Orlando, G., Cappelli, G., Esposito, R., & Palella, F. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn499 · Cited by 17
Cited by
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Trépo, C., Chan, H. L. Y., & Lok, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60220-8 · Cited by 1,623
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Sax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
Metadata
- Authors
- Cooper, R. D., Wiebe, N., Smith, N., Keiser, P., Naicker, S., & Tonelli, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09
- Volume
- 51
- Issue
- 5
- Pages
- 496-505
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2162761942
- Cited by
- 565
- References
- 52
- FWCI
- 27.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.